Search results :

Anidulafungin

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: J02AX06

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5
Infection Infection 32.9% - 64% x x x
Infestation Infestation NOS 32.9% - 64% x x
Mediastinal disorder Mediastinal disorder 44% - 51.1% x x
Gastrointestinal disorder Gastrointestinal disorder 35.3% - 61.8% x x x
Mental disorder Mental disorder 36% - 36.6% x
Angiopathy Angiopathy 32.8% - 38.2% x x x
Malnutrition Malnutrition 15.3% - 48.8% x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue 22.9% - 25.6% x x x
Connective tissue disorder Connective tissue disorder 20% - 20.6% x
Bacteraemia Bacteraemia 17.6% - 18.4% x
Nervous system disorder Nervous system disorder 12% - 24.8% x x x
Urinary tract infection Urinary tract infection 14.5% - 17.6% x
Hypotension Hypotension 14.4% - 14.5% x x x x x
Insomnia Insomnia 9.6% - 15.3% x
Oedema peripheral Oedema peripheral 10.7% - 12.8% x x x
Hypomagnesaemia Hypomagnesaemia 11.2% - 11.5% x x x
Blood alkaline phosphatase increased Blood alkaline phosphatase increased 1.5% - 11.5% x x
Pneumonia Pneumonia 6.11% - 15.2% x
Constipation Constipation 8.4% - 11.2% x x x
Abdominal pain Abdominal pain 6.11% - 12.8% x
Gastrointestinal pain Abdominal pain 6.11% - 12.8% x
Pleural effusion Pleural effusion 8.8% - 9.92% x
Anaemia Anaemia 7.31% - 16% x
Hyperkalaemia Hyperkalaemia 6.11% - 11.2% x x x x
Back pain Back pain 5.34% - 10.4% x x x
Sepsis Sepsis 6.87% - 8.8% x
Confusional state Confusional state 7.63% - 8% x
Feeling abnormal Confusional state 7.63% - 8% x
Hypertension Hypertension 4% - 11.5% x x x x x
Hypoglycaemia Hypoglycaemia 6.87% - 8% x
Dyspnoea Dyspnoea 3.2% - 11.5% x x x x x
Dyspepsia Dyspepsia 6.67% - 6.98% x x x
Dyspepsia aggravated 0.333% - 0.997% x x
Decubitus ulcer Decubitus ulcer 5.34% - 8% x
Hyperglycaemia Hyperglycaemia 6.11% - 6.4% x x x x
Cough Cough 5.6% - 6.87% x x x
White blood cell count increased White blood cell count increased 2.4% - 8.4% x
Hepatic enzyme increased Hepatic enzyme increased 1.5% - 11.2% x x x
Chest pain Chest pain 4.8% - 5.34% x
Leukocytosis Leukocytosis 4.8% - 5.34% x
Depression Depression 4% - 6.11% x
Candida infection Oral candidiasis 3.32% - 5% x x x x
Oral candidiasis Oral candidiasis 3.32% - 5% x x x x
Dehydration Dehydration 1.6% - 6.11% x x
Respiratory distress Respiratory distress 1.6% - 6.11% x
Thrombocytosis Thrombocytosis 0.8% - 6.11% x
Blood creatinine increased Blood creatinine increased 0.8% - 5.34% x x x
Diarrhoea Diarrhoea 1.6% - 18.4% x x x x x
Loose stools x
Hypokalaemia Hypokalaemia 2.4% - 25.2% x x x x x
Deep vein thrombosis Deep vein thrombosis 0.763% - 9.92% x x x x
Pruritus Pruritus 2.3% x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased 2.3% x
Menopausal symptoms Hot flush 2.3% x x x x x
Hot flush Hot flush 2.3% x x x x x
Blood bilirubin increased Blood bilirubin increased 1.5% x x
Headache Headache 0.997% - 8.4% x x x x x
Dermatitis Rash 0.664% - 1.5% x x x x x
Rash Rash 0.664% - 1.5% x x x x x
Nausea Nausea 0.997% - 24.4% x x x x x
Neutropenia Neutropenia 1% x x
Leukopenia Leukopenia 0.667% - 1.33% x x x
Phlebitis Phlebitis 0.667% - 1.33% x x
Body temperature increased Body temperature increased 0.667% - 18.4% x x x
Vomiting Vomiting 0.667% - 17.6% x x x x
Urticaria Urticaria 0.8% x x x x x
Anaphylactic shock Anaphylactic shock postmarketing x x
Bronchospasm Bronchospasm postmarketing x x
Angioedema Angioedema x x x
Sinus arrhythmia Sinus arrhythmia x x x x
Atrial fibrillation Atrial fibrillation x x x x
Coagulopathy Coagulopathy x x x x
Bundle branch block Bundle branch block x x x
Cholestasis Cholestasis x x x x x
Clostridial infection Clostridial infection x x x x
Dizziness Dizziness x x x
Eye disorder Eye disorder x
Faecal incontinence Faecal incontinence x x x
Flushing Flushing x x x x x
Cardiac disorder Cardiac disorder x
Hypercalcaemia Hypercalcaemia x x x
Hypernatraemia Hypernatraemia x x x
Hypersensitivity Hypersensitivity x
Immune system disorder Immune system disorder x
Multi-organ failure Multi-organ failure x
Convulsion Convulsion x x x x x
Cerebrovascular accident Cerebrovascular accident x
Thrombocytopenia Thrombocytopenia x x x
Erythema Erythema x x x
Urethral disorder Urinary tract disorder x
Urinary tract disorder Urinary tract disorder x
Fungaemia Fungaemia x x
Bundle branch block right Bundle branch block right x
Amylase increased Amylase increased x
Blood urea increased Blood urea increased x
Urea increased x
Blood creatine phosphokinase increased Creatine phosphokinase increased x
Drug level decreased Drug level decreased x
Ventricular extrasystoles Ventricular extrasystoles x x x x
Gamma-glutamyltransferase increased Gamma-glutamyltransferase increased x x
Injection site reaction Injection site reaction x
Liver function test abnormal Liver function test abnormal x x x x
Hepatic necrosis Hepatic necrosis x x x
Eye pain Eye pain x x x x
Prothrombin level increased Prothrombin level increased x x x
Electrocardiogram QT prolonged Electrocardiogram QT prolonged x x x
Aspartate aminotransferase increased Aspartate aminotransferase increased x x
Systemic candida Systemic candida x
Abdominal pain upper Abdominal pain upper x x x x
Hepatobiliary disease Hepatobiliary disease x x
Vision blurred Vision blurred x x x x
Rash maculo-papular Rash maculo-papular x
Chills Rigors x x x
Pruritus generalised Pruritus generalised x
Visual impairment Visual disturbance x x x x
Lipase increased Lipase increased x
Hyperhidrosis Sweating increased x x x
White blood cell count decreased White blood cell count decreased x
Blood potassium decreased Potassium low x
Infusion related reaction Infusion related reaction x x x
Infusion site pain Infusion site pain x
Thrombophlebitis superficial Thrombophlebitis superficial x x x
Rash papular Rash papular x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

anidulafungin / anidulafungin

Side effects:38
Source:EMA

ANIDULAFUNGIN / ERAXIS

Side effects:51
Source:Health Canada

ANIDULAFUNGIN / ERAXIS

Side effects:57
Source:FDA

ANIDULAFUNGIN / ERAXIS

Side effects:58
Source:FDA

ANIDULAFUNGIN

Side effects:93
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label